These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 2876554

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone.
    Helgeland A.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S474-6. PubMed ID: 6208414
    [Abstract] [Full Text] [Related]

  • 24. The effects of beta-adrenergic blocking agents on blood lipid levels.
    Wolinsky H.
    Clin Cardiol; 1987 Oct; 10(10):561-6. PubMed ID: 2889552
    [Abstract] [Full Text] [Related]

  • 25. The effects of the beta-adrenergic-blocking agents, timolol and carteolol, on plasma lipids and lipoproteins in Japanese glaucoma patients.
    Yamamoto T, Kitazawa Y, Noma A, Maeda S, Kato A, Ando Y, Ido T, Inazumi K, Hayakawa T, Goto Y, Ichien M.
    J Glaucoma; 1996 Aug; 5(4):252-7. PubMed ID: 8795770
    [Abstract] [Full Text] [Related]

  • 26. Association of hypertensive status and its drug treatment with lipid and haemostatic factors in middle-aged men: the PRIME study.
    Marques-Vidal P, Montaye M, Haas B, Bingham A, Evans A, Juhan-Vague I, Ferrières J, Luc G, Amouyel P, Arveiler D, McMaster D, Ruidavets JB, Bard JM, Scarabin PY, Ducimetière P.
    J Hum Hypertens; 2000 Aug; 14(8):511-8. PubMed ID: 10962519
    [Abstract] [Full Text] [Related]

  • 27. Treating hypertension and cardiovascular risk: are there trade-offs?
    Grimm RH.
    Am Heart J; 1990 Mar; 119(3 Pt 2):729-32; discussion 732. PubMed ID: 1968699
    [Abstract] [Full Text] [Related]

  • 28. Effect of beta blockers on blood lipid profile.
    Lehtonen A.
    Am Heart J; 1985 May; 109(5 Pt 2):1192-6. PubMed ID: 2859784
    [Abstract] [Full Text] [Related]

  • 29. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
    Sirtori CR, Johnson B, Vaccarino V, Montanari G, Cremoncini M, Gianfranceschi G, Sirtori M, Dujovne CA.
    Clin Pharmacol Ther; 1989 Jun; 45(6):617-26. PubMed ID: 2567218
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Adrenergic mechanisms and their significance for plasma lipid concentrations].
    Day JL.
    Wien Med Wochenschr; 1982 Jun; 132 Spec No 2():19-22. PubMed ID: 6132497
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The effect of nifedipine on plasma lipids in patients with essential hypertension.
    Lehtonen A, Tanskanen A, Lehto H, Jarvensiven P.
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):357-8. PubMed ID: 3460970
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
    Bell DS, Bakris GL, McGill JB.
    Diabetes Obes Metab; 2009 Mar; 11(3):234-8. PubMed ID: 18564334
    [Abstract] [Full Text] [Related]

  • 38. The effects of antihypertensive agents on serum lipids and lipoproteins.
    Lardinois CK, Neuman SL.
    Arch Intern Med; 1988 Jun; 148(6):1280-8. PubMed ID: 2897834
    [Abstract] [Full Text] [Related]

  • 39. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R.
    Artery; 1982 Jun; 10(4):266-85. PubMed ID: 7181672
    [Abstract] [Full Text] [Related]

  • 40. Effect of bucindolol on plasma HDL cholesterol subfractions and other plasma lipids in essential hypertensive patients.
    Lehtonen A, Tanskanen A, Temmerman J.
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):448-51. PubMed ID: 2888737
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.